Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by 13X2413

T.ONC

RE:.50 lower than the last PP price

Bargain price for anybody that wants to take over this highly sought after...

October 18, 2023

V.HPQ

RE:RE:RE:New Press Release - HPQ Secures Third-Fumed Silica NDA, as Interest in Testing of Its Commercial-Grade Silica Material Continues to Grow

Everything looks great, I just wish that 24 month timeframe wasn't...

October 18, 2023

T.ONC

RE:Lots of sensible questions, answers complicated

Great post. Sensible and relevant. Thanks for that. 

October 16, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023

Not quite the answer I was looking for. :)

October 16, 2023

T.ONC

RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023

You continue to be positive and it's clear you're much smarter than I...

October 16, 2023

T.ONC

RE:Stock Buyout Coming?

More non event news today to allow this to sink further. Or stink further...

October 16, 2023

T.ONC

RE:RE:RE:2 things!

See. So upset, can't even spell FRUSTRATING. 

October 13, 2023

T.ONC

RE:RE:2 things!

Even with grants, fireside chats and fantasy takeover dreams, we're down...

October 13, 2023

T.ONC

This is worrisome….

Down 14 cents on very little volume. Where are the buyers? Sellers just...

October 12, 2023

T.ONC

RE:RE:RE:RE:Dear Matt

Judging by another down day, you're not the only one sick of this. I just...

October 11, 2023

V.FUU

Confused.

Thought today's news would have been a boost. No excitement whatsoever...

October 6, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:G12C/G12V KRAS mutation in PC & CRC patients respond to Pela

Noteable is right, this stock is undervalued and getting more so everyday...

October 6, 2023

T.ONC

RE:RE:RE:Deal or no deal!

Investors seem to think its overvalued, judging by the constant pressure on...

October 3, 2023

T.ONC

What we need

Is another fireside bedroom story to get this baby really rolling. 

October 2, 2023

T.ONC

RE:RE:Fireside Chat

Good one! Better than most of the BS you spew  

September 28, 2023

T.ONC

Fireside Chat

Judging by the price action, I'm assuming somebody p*ssed on the flames...

September 28, 2023

V.HPQ

RE:Big manipulation happening

It was sure a lot more promising such a short time ago. Down 40% is a lot...

September 25, 2023

T.ONC

RE:RE:RE:RE:RE:Novartis returns anti-PD1 to Chinese based company BeiGene

You think I'd be posting here if I sold. Still long, that's why I'...

September 20, 2023

T.ONC

RE:RE:RE:Novartis returns anti-PD1 to Chinese based company BeiGene

Can't they come up with something better than a fireside chat? Opening...

September 20, 2023

T.ONC

RE:RE:RE:RE:RE:RE:G12C/G12V KRAS mutation in PC & CRC patients respond to Pela

Really? Interesting, but can you keep directly focused on ONC. 

September 18, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Tidal Care Inc.

Tidal Care Inc. P.TDL

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ... view more »